Catalyst Biosciences Signs Two Key Deals
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 7 (Table of Contents)
Published: 21 Jul-2009
DOI: 10.3833/pdr.v2009.i7.1137 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Catalyst Biosciences, inventor of Alterase™ therapeutics, has secured two big deals: one with Wyeth for hemophilia products including the lead product, CB 813, and another deal with MedImmune to develop drug candidates against two targets, of which one will address inflammatory and autoimmune diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS